Annis Gardner Whiting Capital Advisors, LLC Merck & Co., Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $355 Billion
- Q3 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 5,789 shares of MRK stock, worth $570,216. This represents 0.19% of its overall portfolio holdings.
Number of Shares
5,789
Previous 7,155
19.09%
Holding current value
$570,216
Previous $891 Million
25.81%
% of portfolio
0.19%
Previous 0.25%
Shares
5 transactions
Others Institutions Holding MRK
# of Institutions
3,803Shares Held
1.9BCall Options Held
13.5MPut Options Held
11.1M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.47 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.83 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $250B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...